Trial Profile
A retrospective study investigating the effect of alglucosidase alfa in patients with pompe disease who reassumed therapy after previous cessation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Nov 2015
Price :
$35
*
At a glance
- Drugs Alglucosidase alfa (Primary)
- Indications Glycogen storage disease type II
- Focus Therapeutic Use
- 24 Nov 2015 New trial record